InvestorsHub Logo
Followers 0
Posts 813
Boards Moderated 0
Alias Born 03/25/2013

Re: Prizzy post# 8387

Saturday, 01/25/2014 3:38:49 PM

Saturday, January 25, 2014 3:38:49 PM

Post# of 18744
Prissy I Don't Make Predictions
Having said that, I think we're going to the moon!
All kidding aside, I don't like making predictions or specific share price calls because it is a total guess. Granted it's all a big guess anyway but when it comes to stocks like these MJ companies, placing a share price based valuation is difficult due to a lack of clarity. With companies like @APL you can estimate using revenues, liabilities, growth patterns/prospects and all sorts of fiduciary info to come up with somewhat accurate "predictions."

If I had to make "predictions", here is what I come up with:

Short Term
The sector is on fire. I see lots of volatility. I wouldn't even dare to make prediction about what's to come. Political news, sector specific news, earnings reports and so many other variables will drive the near term. I expect lots of bullish activity due to the Golden Crosses everywhere. I also expect decent pullbacks due to profit taking, weak hands and flippers.

Long Term
MJNA - I compare MJNA to HerbalLife, which is a $30b company (although the government may be looking into that and the owner didn't fare so well with his health). If MJNA could grow their empire to be like HerbaLife you're looking at $20+ per share.

ERBB - if ERBB can achieve MDBXs valuation, that at least .20/share. If ERBB can get their vending machines up and running in multiple states, that could make Tranzbyte a multi-billion dollar entity. With 2.8b shares outstanding and a little less than twice that available, even if the entire available float is activated, ERBB could be $2-10/share easily.

CBIS - CBIS needs to make some clinical progress. If they can keep the company running over the next 5 years and develop treatments for skin cancer, one of the most common cancers, CBIS could do sales in the billions just like Merck or Pfizer. One single drug can draw billions in revenue. That would out CBIS in the $50b range or $50/share.

There is also a large potential for buyout with many of these companies. MCIG could easily be absorbed my Pal Mal or other major players so they don't lose step in their industry.

Who knows where this goes. Maybe it goes nowhere. Obviously, at the current valuations, my predictions above are wild, pie in the sky optimistic outlooks but that's the beauty of the sector. There are so many unknowns, so many variables, so much progress and so much fking EXCITEMENT!!!!!

"Emancipate youself from mental slavery, none but ourselves can free our mind"
-Bob Marley

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.